Zhejiang Jolly Pharmaceutical Co Ltd

Zhejiang Jolly Pharmaceutical Co Ltd maintains a strong liquidity position with a current ratio of 1.79, indicating the ability to cover short-term obligations. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The price-to-book ratio of 3.18 suggests the market is valuing the company at a premium to its book value, while the price-to-earnings ratio of 16.0 reflects a moderate valuation relative to earnings. The company's profitability is robust, with a return on equity (ROE) of 19.87% and a return on assets (ROA) of 13.41%, both exceeding the typical thresholds for the pharmaceutical industry. The gross margin of 61.25% (calculated from gross profit of 1.86 billion CNY on revenue of 3.04 billion CNY) is also strong, indicating efficient cost management. Zhejiang Jolly Pharmaceutical Co Ltd operates primarily in the domestic Chinese market, with no disclosed international revenue segments. The company's revenue concentration in a single geographic region may expose it to regulatory and economic risks specific to China. The company's revenue growth is expected to remain stable, with analysts forecasting an EPS of 1.19 CNY for the current fiscal year, compared to the actual EPS of 0.91 CNY in the most recent period. This suggests a positive earnings outlook, though the capital expenditure of -287.14 million CNY indicates a reduction in investment in physical assets. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.22 is relatively low, suggesting a conservative capital structure. However, the negative net cash position after subtracting total debt is a concern for liquidity. Recent investor relations data shows a strong analyst consensus, with a mean recommendation of 1.00 (strong buy) and two strong-buy ratings. This indicates a positive sentiment among analysts, though the company must maintain its earnings performance to meet expectations.